Literature DB >> 1347196

Involvement of multiple chromosome 17p loci in medulloblastoma tumorigenesis.

P H Cogen1, L Daneshvar, A K Metzger, G Duyk, M S Edwards, V C Sheffield.   

Abstract

Loss of heterozygosity for sequences located on chromosome 17p in several tumor types is often associated with mutations in the tumor suppressor gene p53. We previously showed consistent deletion of chromosome 17p12-13.1 in medulloblastoma, a common childhood brain tumor. Using denaturing gradient gel electrophoresis and direct sequencing, we have detected p53 mutations in only two of 20 medulloblastoma specimens. Moreover, additional RFLP studies of these 20 specimens showed loss of heterozygosity at a more distal and distinct site, 17p13.3. Deletion of 17p almost invariably signified a negative prognosis. Our results suggest that p53 mutations may contribute to the pathogenesis of medulloblastoma in relatively few cases. The consistent deletion of other discrete loci on 17p suggests that additional or alternative tumor suppressor genes may contribute to the tumor's phenotype.

Entities:  

Mesh:

Year:  1992        PMID: 1347196      PMCID: PMC1684269     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

Review 1.  Second international workshop on human chromosome 17.

Authors:  P R Fain; E Solomon; D H Ledbetter
Journal:  Cytogenet Cell Genet       Date:  1991

2.  Clonal genomic alterations in glioma malignancy stages.

Authors:  C D James; E Carlbom; J P Dumanski; M Hansen; M Nordenskjold; V P Collins; W K Cavenee
Journal:  Cancer Res       Date:  1988-10-01       Impact factor: 12.701

3.  A genetic map of human chromosome 17p.

Authors:  E C Wright; D E Goldgar; P R Fain; D F Barker; M H Skolnick
Journal:  Genomics       Date:  1990-05       Impact factor: 5.736

4.  Characterization of the human p53 gene.

Authors:  P Lamb; L Crawford
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

5.  Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

Authors:  S Srivastava; Z Q Zou; K Pirollo; W Blattner; E H Chang
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

6.  Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.

Authors:  C T Fong; N C Dracopoli; P S White; P T Merrill; R C Griffith; D E Housman; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

7.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

Authors:  R C Seeger; G M Brodeur; H Sather; A Dalton; S E Siegel; K Y Wong; D Hammond
Journal:  N Engl J Med       Date:  1985-10-31       Impact factor: 91.245

8.  Medulloblastoma: presentation, diagnosis and management.

Authors:  R J Packer; J L Finlay
Journal:  Oncology (Williston Park)       Date:  1988-09       Impact factor: 2.990

9.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.

Authors:  S J Baker; E R Fearon; J M Nigro; S R Hamilton; A C Preisinger; J M Jessup; P vanTuinen; D H Ledbetter; D F Barker; Y Nakamura; R White; B Vogelstein
Journal:  Science       Date:  1989-04-14       Impact factor: 47.728

10.  Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis.

Authors:  C Coles; A M Thompson; P A Elder; B B Cohen; I M Mackenzie; G Cranston; U Chetty; J Mackay; M Macdonald; Y Nakamura
Journal:  Lancet       Date:  1990-09-29       Impact factor: 79.321

View more
  28 in total

1.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

Authors:  H Dannenberg; E J Speel; J Zhao; P Saremaslani; E van Der Harst; J Roth; P U Heitz; H J Bonjer; W N Dinjens; W J Mooi; P Komminoth; R R de Krijger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

Review 2.  Hypomelanosis of Ito and brain abnormalities: MRI findings and literature review.

Authors:  J Steiner; C Adamsbaum; I Desguerres; G Lalande; F Raynaud; G Ponsot; G Kalifa
Journal:  Pediatr Radiol       Date:  1996-11

Review 3.  Tumor suppressor genes and medulloblastoma.

Authors:  P H Cogen; J D McDonald
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

4.  Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.

Authors:  Chitra Sarkar; Pulakesh Pramanik; Asis Kumar Karak; Partho Mukhopadhyay; Mehar Chand Sharma; Varindera Paul Singh; Veer Singh Mehta
Journal:  J Neurooncol       Date:  2002-08       Impact factor: 4.130

5.  Loss of heterozygosity analysis of chromosome 17p13.1-13.3 and its correlation with clinical outcome in medulloblastomas.

Authors:  Hye Lim Jung; Kyu-Chang Wang; Seung-Ki Kim; Ki Woong Sung; Hong Hoe Koo; Hee Young Shin; Hyo Seop Ahn; Hyung Jin Shin; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 6.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

7.  Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization.

Authors:  G Sauter; G Deng; H Moch; R Kerschmann; K Matsumura; S De Vries; T George; J Fuentes; P Carroll; M J Mihatsch
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors.

Authors:  Jordi Berenguer; Antonio Herrera; Laura Vuolo; Blanca Torroba; Franc Llorens; Lauro Sumoy; Sebastian Pons
Journal:  Mol Cell Biol       Date:  2013-05-13       Impact factor: 4.272

Review 9.  Molecular biology of pediatric gliomas.

Authors:  C Raffel
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

10.  The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells.

Authors:  Hirokatsu Osawa; Christian A Smith; Young Shin Ra; Paul Kongkham; James T Rutka
Journal:  Neuro Oncol       Date:  2008-12-16       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.